Fetal microchimeric cells in a fetus-treats-its-mother paradigm do not contribute to dystrophin production in serially parous mdx females.

Throughout every pregnancy, genetically distinct fetal microchimeric stem/progenitor cells (FMCs) engraft in the mother, persist long after delivery, and may home to damaged maternal tissues. Phenotypically normal fetal lymphoid progenitors have been described to develop in immunodeficient mothers in a fetus-treats-its-mother paradigm. Since stem cells contribute to muscle repair, we assessed this paradigm in the mdx mouse model of Duchenne muscular dystrophy. mdx females were bred serially to either ROSAeGFP males or mdx males to obtain postpartum microchimeras that received either wild-type FMCs or dystrophin-deficient FMCs through serial gestations. To enhance regeneration, notexin was injected into the tibialis anterior of postpartum mice. FMCs were detected by qPCR at a higher frequency in injected compared to noninjected side muscle (P=0.02). However, the number of dystrophin-positive fibers was similar in mothers delivering wild-type compared to mdx pups. In addition, there was no correlation between FMC detection and percentage dystrophin, and no GFP+ve FMCs were identified that expressed dystrophin. In 10/11 animals, GFP+ve FMCs were detected by immunohistochemistry, of which 60% expressed CD45 with 96% outside the basal lamina defining myofiber contours. Finally we confirmed lack of FMC contribution to statellite cells in postpartum mdx females mated with Myf5-LacZ males. We conclude that the FMC contribution to regenerating muscles is insufficient to have a functional impact.

[1]  J. Tripodi,et al.  Fetal Cells Traffic to Injured Maternal Myocardium and Undergo Cardiac Differentiation , 2012, Circulation research.

[2]  K. Khosrotehrani,et al.  Fetal progenitor cells naturally transferred through pregnancy participate in inflammation and angiogenesis during wound healing , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  G. Dawe,et al.  Pregnancy-associated progenitor cells differentiate and mature into neurons in the maternal brain. , 2010, Stem cells and development.

[4]  A. Varki,et al.  A Human-Specific Deletion in Mouse Cmah Increases Disease Severity in the mdx Model of Duchenne Muscular Dystrophy , 2010, Science Translational Medicine.

[5]  S. Hirata,et al.  Fetal cell microchimerism develops through the migration of fetus-derived cells to the maternal organs early after implantation. , 2010, Journal of reproductive immunology.

[6]  G. Cossu,et al.  Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. , 2010, The Journal of clinical investigation.

[7]  F. Muntoni,et al.  Mature Adult Dystrophic Mouse Muscle Environment Does Not Impede Efficient Engrafted Satellite Cell Regeneration and Self‐Renewal , 2009, Stem cells.

[8]  H. Tighiouart,et al.  Fetal Cells in the Pregnant Mouse Are Diverse and Express a Variety of Progenitor and Differentiated Cell Markers1 , 2009, Biology of reproduction.

[9]  K. Khosrotehrani,et al.  Tumorigenesis and Neoplastic Progression Fetal Microchimeric Cells Participate in Tumour Angiogenesis in Melanomas Occurring during Pregnancy , 2010 .

[10]  S. Teoh,et al.  Superior Osteogenic Capacity for Bone Tissue Engineering of Fetal Compared with Perinatal and Adult Mesenchymal Stem Cells , 2009, Stem cells.

[11]  H. Tighiouart,et al.  Fetomaternal Trafficking in the Mouse Increases as Delivery Approaches and Is Highest in the Maternal Lung1 , 2008, Biology of reproduction.

[12]  N. Habib,et al.  High frequency of fetal cells within a primitive stem cell population in maternal blood. , 2008, Human reproduction.

[13]  K. Khosrotehrani,et al.  Pregnancy allows the transfer and differentiation of fetal lymphoid progenitors into functional T and B cells in mothers , 2008, The Journal of Immunology.

[14]  J. Chan,et al.  Widespread Distribution and Muscle Differentiation of Human Fetal Mesenchymal Stem Cells After Intrauterine Transplantation in Dystrophic mdx Mouse , 2007, Stem cells.

[15]  J. Chan,et al.  Human First‐Trimester Fetal MSC Express Pluripotency Markers and Grow Faster and Have Longer Telomeres Than Adult MSC , 2007, Stem cells.

[16]  F. Chareyre,et al.  Maternal neoangiogenesis during pregnancy partly derives from fetal endothelial progenitor cells , 2007, Proceedings of the National Academy of Sciences.

[17]  G. Lynch,et al.  Notexin causes greater myotoxic damage and slower functional repair in mouse skeletal muscles than bupivacaine , 2006, Muscle & nerve.

[18]  Z. Yablonka-Reuveni,et al.  The Skeletal Muscle Satellite Cell: The Stem Cell That Came in From the Cold , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[19]  K. Davies,et al.  Expansion of revertant fibers in dystrophic mdx muscles reflects activity of muscle precursor cells and serves as an index of muscle regeneration , 2006, Journal of Cell Science.

[20]  Marius Wernig,et al.  The vast majority of bone-marrow-derived cells integrated into mdx muscle fibers are silent despite long-term engraftment. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[21]  K. Khosrotehrani,et al.  Natural history of fetal cell microchimerism during and following murine pregnancy. , 2005, Journal of reproductive immunology.

[22]  S. Cobbold,et al.  Effects of T-lymphocyte depletion on muscle fibrosis in the mdx mouse. , 2005, The American journal of pathology.

[23]  P. Rigby,et al.  Myf5 expression in satellite cells and spindles in adult muscle is controlled by separate genetic elements. , 2004, Developmental biology.

[24]  J. Chan,et al.  Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy , 2004, The Lancet.

[25]  K. Khosrotehrani,et al.  Transfer of fetal cells with multilineage potential to maternal tissue. , 2004, JAMA.

[26]  M. Goodell,et al.  Skeletal Muscle Fiber‐Specific Green Autofluorescence: Potential for Stem Cell Engraftment Artifacts , 2004, Stem cells.

[27]  Emanuela Gussoni,et al.  Stem cell therapy for muscular dystrophy , 2004, Expert opinion on biological therapy.

[28]  Lin Yi,et al.  Contribution of hematopoietic stem cells to skeletal muscle , 2003, Nature Medicine.

[29]  J. Sanes.  The Basement Membrane/Basal Lamina of Skeletal Muscle* , 2003, The Journal of Biological Chemistry.

[30]  L. Kunkel,et al.  Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation. , 2002, The Journal of clinical investigation.

[31]  I. Verma,et al.  Biodistribution and toxicity studies of VSVG-pseudotyped lentiviral vector after intravenous administration in mice with the observation of in vivo transduction of bone marrow. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[32]  J. Morgan,et al.  Evidence for a myogenic stem cell that is exhausted in dystrophic muscle. , 2000, Journal of cell science.

[33]  S. Wilton,et al.  Massive Idiosyncratic Exon Skipping Corrects the Nonsense Mutation in Dystrophic Mouse Muscle and Produces Functional Revertant Fibers by Clonal Expansion , 2000, The Journal of cell biology.

[34]  K. Davies,et al.  Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene , 2000, Gene Therapy.

[35]  Nicolas Deconinck,et al.  Expression of full-length utrophin prevents muscular dystrophy in mdx mice , 1998, Nature Medicine.

[36]  G Cossu,et al.  Muscle regeneration by bone marrow-derived myogenic progenitors. , 1998, Science.

[37]  S. Winder.  REVIEW: The membrane--cytoskeleton interface: the role of dystrophin and utrophin , 1997, Journal of Muscle Research & Cell Motility.

[38]  G. Weil,et al.  Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. Lefaucheur,et al.  The cellular events of injured muscle regeneration depend on the nature of the injury , 1995, Neuromuscular Disorders.

[40]  C. Rodeck,et al.  The time of appearance, and quantitation, of fetal DNA in the maternal circulation. , 1994, Annals of the New York Academy of Sciences.

[41]  E A Barnard,et al.  The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. , 1989, Science.

[42]  T. Partridge,et al.  THE mdx MOUSE SKELETAL MUSCLE MYOPATHY: I. A HISTOLOGICAL, MORPHOMETRIC AND BIOCHEMICAL INVESTIGATION , 1988, Neuropathology and applied neurobiology.

[43]  N. Fisk,et al.  Microchimeric fetal cells cluster at sites of tissue injury in lung decades after pregnancy. , 2008, Reproductive biomedicine online.

[44]  R. Vater,et al.  The fate of dystrophin during the degeneration and regeneration of the soleus muscle of the rat , 2004, Acta Neuropathologica.

[45]  J. Nelson.  Microchimerism and the causation of scleroderma. , 1998, Scandinavian journal of rheumatology. Supplement.